-
Je něco špatně v tomto záznamu ?
Control of anterior GRadient 2 (AGR2) dimerization links endoplasmic reticulum proteostasis to inflammation
M. Maurel, J. Obacz, T. Avril, YP. Ding, O. Papadodima, X. Treton, F. Daniel, E. Pilalis, J. Hörberg, W. Hou, MC. Beauchamp, J. Tourneur-Marsille, D. Cazals-Hatem, L. Sommerova, A. Samali, J. Tavernier, R. Hrstka, A. Dupont, D. Fessart, F. Delom,...
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2009
Free Medical Journals
od 2009
PubMed Central
od 2009
Europe PubMed Central
od 2009
ProQuest Central
od 2009-04-01
Open Access Digital Library
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Medline Complete (EBSCOhost)
od 2011-01-01
Health & Medicine (ProQuest)
od 2009-04-01
Wiley-Blackwell Open Access Titles
od 2009 do 2023
ROAD: Directory of Open Access Scholarly Resources
od 2008
PubMed
31040128
DOI
10.15252/emmm.201810120
Knihovny.cz E-zdroje
- MeSH
- endoplazmatické retikulum genetika metabolismus MeSH
- HEK293 buňky MeSH
- homeostáze proteinů * MeSH
- lidé MeSH
- mukoproteiny genetika metabolismus MeSH
- multimerizace proteinu * MeSH
- myši MeSH
- onkogenní proteiny genetika metabolismus MeSH
- stres endoplazmatického retikula * MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Anterior gradient 2 (AGR2) is a dimeric protein disulfide isomerase family member involved in the regulation of protein quality control in the endoplasmic reticulum (ER). Mouse AGR2 deletion increases intestinal inflammation and promotes the development of inflammatory bowel disease (IBD). Although these biological effects are well established, the underlying molecular mechanisms of AGR2 function toward inflammation remain poorly defined. Here, using a protein-protein interaction screen to identify cellular regulators of AGR2 dimerization, we unveiled specific enhancers, including TMED2, and inhibitors of AGR2 dimerization, that control AGR2 functions. We demonstrate that modulation of AGR2 dimer formation, whether enhancing or inhibiting the process, yields pro-inflammatory phenotypes, through either autophagy-dependent processes or secretion of AGR2, respectively. We also demonstrate that in IBD and specifically in Crohn's disease, the levels of AGR2 dimerization modulators are selectively deregulated, and this correlates with severity of disease. Our study demonstrates that AGR2 dimers act as sensors of ER homeostasis which are disrupted upon ER stress and promote the secretion of AGR2 monomers. The latter might represent systemic alarm signals for pro-inflammatory responses.
Apoptosis Research Centre School of Natural Sciences NUI Galway Galway Ireland
Biochemistry Department McGill University Life Sciences Complex Montréal QC Canada
Department of Chemistry and Molecular Biology University of Gothenburg Göteborg Sweden
Institute of Biology Medicinal Chemistry and Biotechnology NHRF Athens Greece
Microscopy Rennes Imaging Centre and Biosit UMS3480 CNRS University of Rennes 1 Rennes Cédex France
Regional Centre for Applied Molecular Oncology Brno Czech Republic
University of Bordeaux Bordeaux France
VIB Department of Medical Protein Research UGent Gent Belgium
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20023891
- 003
- CZ-PrNML
- 005
- 20201214131602.0
- 007
- ta
- 008
- 201125s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.15252/emmm.201810120 $2 doi
- 035 __
- $a (PubMed)31040128
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Maurel, Marion $u INSERM U1242, "Chemistry, Oncogenesis Stress Signaling", University of Rennes, Rennes, France. Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France. VIB Department of Medical Protein Research, UGent, Gent, Belgium. Apoptosis Research Centre, School of Natural Sciences, NUI Galway, Galway, Ireland.
- 245 10
- $a Control of anterior GRadient 2 (AGR2) dimerization links endoplasmic reticulum proteostasis to inflammation / $c M. Maurel, J. Obacz, T. Avril, YP. Ding, O. Papadodima, X. Treton, F. Daniel, E. Pilalis, J. Hörberg, W. Hou, MC. Beauchamp, J. Tourneur-Marsille, D. Cazals-Hatem, L. Sommerova, A. Samali, J. Tavernier, R. Hrstka, A. Dupont, D. Fessart, F. Delom, ME. Fernandez-Zapico, G. Jansen, LA. Eriksson, DY. Thomas, L. Jerome-Majewska, T. Hupp, A. Chatziioannou, E. Chevet, E. Ogier-Denis,
- 520 9_
- $a Anterior gradient 2 (AGR2) is a dimeric protein disulfide isomerase family member involved in the regulation of protein quality control in the endoplasmic reticulum (ER). Mouse AGR2 deletion increases intestinal inflammation and promotes the development of inflammatory bowel disease (IBD). Although these biological effects are well established, the underlying molecular mechanisms of AGR2 function toward inflammation remain poorly defined. Here, using a protein-protein interaction screen to identify cellular regulators of AGR2 dimerization, we unveiled specific enhancers, including TMED2, and inhibitors of AGR2 dimerization, that control AGR2 functions. We demonstrate that modulation of AGR2 dimer formation, whether enhancing or inhibiting the process, yields pro-inflammatory phenotypes, through either autophagy-dependent processes or secretion of AGR2, respectively. We also demonstrate that in IBD and specifically in Crohn's disease, the levels of AGR2 dimerization modulators are selectively deregulated, and this correlates with severity of disease. Our study demonstrates that AGR2 dimers act as sensors of ER homeostasis which are disrupted upon ER stress and promote the secretion of AGR2 monomers. The latter might represent systemic alarm signals for pro-inflammatory responses.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a endoplazmatické retikulum $x genetika $x metabolismus $7 D004721
- 650 12
- $a stres endoplazmatického retikula $7 D059865
- 650 _2
- $a HEK293 buňky $7 D057809
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a mukoproteiny $x genetika $x metabolismus $7 D009088
- 650 _2
- $a onkogenní proteiny $x genetika $x metabolismus $7 D015513
- 650 12
- $a multimerizace proteinu $7 D055503
- 650 12
- $a homeostáze proteinů $7 D000074702
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Obacz, Joanna $u INSERM U1242, "Chemistry, Oncogenesis Stress Signaling", University of Rennes, Rennes, France. Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France.
- 700 1_
- $a Avril, Tony $u INSERM U1242, "Chemistry, Oncogenesis Stress Signaling", University of Rennes, Rennes, France. Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France.
- 700 1_
- $a Ding, Yong-Ping $u INSERM, UMR1149, Team «Gut Inflammation», Research Centre of Inflammation, Paris, France. Université Paris-Diderot Sorbonne Paris-Cité, Paris, France. APHP Beaujon Hospital Clichy la Garenne, Paris, France.
- 700 1_
- $a Papadodima, Olga $u Institute of Biology, Medicinal Chemistry & Biotechnology, NHRF, Athens, Greece.
- 700 1_
- $a Treton, Xavier $u INSERM, UMR1149, Team «Gut Inflammation», Research Centre of Inflammation, Paris, France. Université Paris-Diderot Sorbonne Paris-Cité, Paris, France. APHP Beaujon Hospital Clichy la Garenne, Paris, France.
- 700 1_
- $a Daniel, Fanny $u INSERM, UMR1149, Team «Gut Inflammation», Research Centre of Inflammation, Paris, France. Université Paris-Diderot Sorbonne Paris-Cité, Paris, France. APHP Beaujon Hospital Clichy la Garenne, Paris, France.
- 700 1_
- $a Pilalis, Eleftherios $u Institute of Biology, Medicinal Chemistry & Biotechnology, NHRF, Athens, Greece. International Centre for Cancer Vaccine Science, Gdansk, Poland.
- 700 1_
- $a Hörberg, Johanna $u Department of Chemistry and Molecular Biology, University of Gothenburg, Göteborg, Sweden.
- 700 1_
- $a Hou, Wenyang $u Departments of Anatomy and Cell Biology, Human Genetics, and Pediatrics, McGill University, Montreal, QC, Canada.
- 700 1_
- $a Beauchamp, Marie-Claude $u Departments of Anatomy and Cell Biology, Human Genetics, and Pediatrics, McGill University, Montreal, QC, Canada.
- 700 1_
- $a Tourneur-Marsille, Julien $u INSERM, UMR1149, Team «Gut Inflammation», Research Centre of Inflammation, Paris, France. Université Paris-Diderot Sorbonne Paris-Cité, Paris, France. APHP Beaujon Hospital Clichy la Garenne, Paris, France.
- 700 1_
- $a Cazals-Hatem, Dominique $u INSERM, UMR1149, Team «Gut Inflammation», Research Centre of Inflammation, Paris, France. Université Paris-Diderot Sorbonne Paris-Cité, Paris, France. APHP Beaujon Hospital Clichy la Garenne, Paris, France.
- 700 1_
- $a Sommerova, Lucia $u Regional Centre for Applied Molecular Oncology (RECAMO), Brno, Czech Republic.
- 700 1_
- $a Samali, Afshin $u Apoptosis Research Centre, School of Natural Sciences, NUI Galway, Galway, Ireland.
- 700 1_
- $a Tavernier, Jan $u VIB Department of Medical Protein Research, UGent, Gent, Belgium.
- 700 1_
- $a Hrstka, Roman $u Regional Centre for Applied Molecular Oncology (RECAMO), Brno, Czech Republic.
- 700 1_
- $a Dupont, Aurélien $u Microscopy Rennes Imaging Centre, and Biosit, UMS3480 CNRS, University of Rennes 1, Rennes Cédex, France.
- 700 1_
- $a Fessart, Delphine $u University of Bordeaux, Bordeaux, France.
- 700 1_
- $a Delom, Frédéric $u University of Bordeaux, Bordeaux, France.
- 700 1_
- $a Fernandez-Zapico, Martin E $u Division of Oncology Research, Department of Oncology, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN, USA.
- 700 1_
- $a Jansen, Gregor $u Biochemistry Department, McGill University Life Sciences Complex, Montréal, QC, Canada.
- 700 1_
- $a Eriksson, Leif A $u Department of Chemistry and Molecular Biology, University of Gothenburg, Göteborg, Sweden.
- 700 1_
- $a Thomas, David Y $u Biochemistry Department, McGill University Life Sciences Complex, Montréal, QC, Canada.
- 700 1_
- $a Jerome-Majewska, Loydie $u Departments of Anatomy and Cell Biology, Human Genetics, and Pediatrics, McGill University, Montreal, QC, Canada.
- 700 1_
- $a Hupp, Ted $u International Centre for Cancer Vaccine Science, Gdansk, Poland. Regional Centre for Applied Molecular Oncology (RECAMO), Brno, Czech Republic. Edinburgh Cancer Research Centre at the Institute of Genetics and Molecular Medicine, Edinburgh University, Edimburgh, UK.
- 700 1_
- $a Chatziioannou, Aristotelis $u Institute of Biology, Medicinal Chemistry & Biotechnology, NHRF, Athens, Greece achatzi@eie.gr eric.chevet@inserm.fr eric.ogier-denis@inserm.fr. e-NIOS PC, Kallithea-Athens, Greece.
- 700 1_
- $a Chevet, Eric $u INSERM U1242, "Chemistry, Oncogenesis Stress Signaling", University of Rennes, Rennes, France achatzi@eie.gr eric.chevet@inserm.fr eric.ogier-denis@inserm.fr. Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France.
- 700 1_
- $a Ogier-Denis, Eric $u INSERM, UMR1149, Team «Gut Inflammation», Research Centre of Inflammation, Paris, France achatzi@eie.gr eric.chevet@inserm.fr eric.ogier-denis@inserm.fr. Université Paris-Diderot Sorbonne Paris-Cité, Paris, France. APHP Beaujon Hospital Clichy la Garenne, Paris, France.
- 773 0_
- $w MED00189522 $t EMBO molecular medicine $x 1757-4684 $g Roč. 11, č. 6 (2019)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31040128 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201214131600 $b ABA008
- 999 __
- $a ok $b bmc $g 1596210 $s 1114567
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 11 $c 6 $e - $i 1757-4684 $m EMBO molecular medicine $n EMBO Mol Med $x MED00189522
- LZP __
- $a Pubmed-20201125